MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma

Published:2017-09 Issue:9 Volume:137 Page:1955-1964
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Bustos Matias A.,Ono Shigeshi,Marzese Diego M.,Oyama Takashi,Iida Yuuki,Cheung Garrett,Nelson Nellie,Hsu Sandy C.,Yu Qiang,Hoon Dave S.B.

Funder

CGI

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference44 articles.

1. Bioinformatic tools for microRNA dissection;Akhtar;Nucleic Acid Res,2016

2. The history and future of targeting cyclin-dependent kinases in cancer therapy;Asghar;Nat Rev Drug Disc,2015

3. Identification of an enhancer that increases miR-200b∼200a∼429 gene expression in breast cancer cells;Attema;PloS One,2013

4. FDA approval: palbociclib for the treatment of postmenopausal patients with estrogen receptor-positive, HER2-negative metastatic breast cancer;Beaver;Clin Cancer Res,2015

5. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition;Bracken;Cancer Res,2008

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pilot Study of Plasma miRNA Signature Panel for Differentiating Single vs Multiglandular Parathyroid Disease;The Journal of Clinical Endocrinology & Metabolism;2024-08-20

2. A New Approach to Melanoma Treatment: microRNAs;Current Topics in Medicinal Chemistry;2024-06

3. Liquid biopsy utilizing miRNA in patients with advanced breast cancer treated with cyclin‑dependent kinase 4/6 inhibitors;Oncology Letters;2024-02-28

4. Spatial profiling of cancer-associated fibroblasts of sporadic early onset colon cancer microenvironment;npj Precision Oncology;2023-11-14

5. In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer;Biomedicines;2023-10-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3